Considering carbon as a lone entity during permafrost thaw is likely to lead to over-confident projections of permafrost carbon emissions, highlights Sophie Opfergelt, Earth and Life Institute, UCLouvain, Belgium.
In the digital age, it is vital to recognise cybersecurity as a real threat, and EHJ & SJ Consultancy Ltd are providing digital solutions to match our world of accelerated digital transformation.
Dr David Carroll from CU Aerospace LLC says that there are advantages to nano-satellites and the Space 2.0 environment, but they exacerbate the problem of orbital debris.
Dr Jatta Jussila discusses the benefits of open innovation and how cross-sectoral partnerships can better solve systemic challenges such as climate change and enable the European Green Deal.
Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.
Dr William Dawson, CEO of OneMedical Group – a national health and wellbeing company delivering NHS services, system leadership and consultancy across the UK – discusses the adoption of technology and opportunities in healthcare post COVID-19.
Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
Here, we learn about the importance of recognising Absenteeism, Presenteeism and Leaveism, so that businesses can proactively address them to reduce costs and support their workers.
Here, Rie Krabsen and Erik Christiansen of EBO Consult continue to disclose the ins and out of district heating, in particular, discussing operation and maintenance.
Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
